The results of the recent IARC Monographs evaluation of the carcinogenicity of acrolein, crotonaldehyde, and arecoline have now been published in The Lancet Oncology. This summary article presents the conclusions of IARC Monographs Meeting 128.
Acrolein and crotonaldehyde were previously evaluated by the Working Group in 1995. Arecoline was evaluated by the Working Group for the first time.
